Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

In reclutamento

Età da 45 a 70 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT05080673

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

University of Rochester Medical Center, Rochester

In reclutamentoFase 2

Età da 18 a 100 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07292298

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

Weill Cornell Medical College, New York
Brooklyn Methodist Hospital - NewYork Presbyterian, New York
New York Presbyterian Hospital - Queens, New York

In reclutamentoFase 2

Età da 18 a 90 · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT05024097

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
e altri 4

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 14 lug 2026 · NCT06205485

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

In reclutamentoStudio osservazionaleVolontari sani benvenuti

Età da 19 a 110 · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT02012699

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

New York Presbyterian Brooklyn Methodist Hospital, Brooklyn
Weill Cornell Medical College, New York
New York Presbyterian Hospital - Queens, New York

In reclutamento

Età da 18 a 90 · Tutti i sessi · Aggiornato il 15 giu 2026 · NCT05943210

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NYU Langone Medical Center, New York

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT06051695

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e altri 1

In reclutamento

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 giu 2026 · NCT06637462

Brodalumab in the Treatment of Immune-Related Adverse Events

Columbia University Irving Medical Center, New York

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 13 mag 2026 · NCT06673329

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e altri 1

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 12 mag 2026 · NCT05672524

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Memorial Sloan Kettering Cancer Center, New York

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT04668872

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Columbia University Irving Medical Center, New York

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 feb 2026 · NCT07433673

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
e altri 2

In reclutamentoStudio osservazionale

Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NYU Langone Health, New York

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2025 · NCT06682793

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

Bassett Healthcare Network, Cooperstown

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 7 mar 2023 · NCT04245683

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.